The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
A prospective study of PHACE syndrome in infantile hemangiomas: Demographic features, clinical findings, and complications
Abstract
PHACE (OMIM no. 606519) is a neurocutaneous syndrome that refers to the association of large, plaque‐like, “segmental” hemangiomas of the face, with one or more of the following anomalies: posterior fossa brain malformations, arterial cerebrovascular anomalies, cardiovascular anomalies, eye anomalies, and ventral developmental defects, specifically s ternal defects and/or supraumbilical raphe. The etiology and pathogenesis of PHACE is unknown, and potential risk factors for the syndrome have not been systematically studied. The purpose of this study was thus to determine (1) the incidence of PHACE and associated anomalies among a large cohort of hemangioma patients, (2) whether certain demographic, prenatal or perinatal risk factors predispose infants to this syndrome, and (3) whether the cutaneous distribution of the hemangioma can be correlated to the types of anomalies present. We undertook a prospective, cohort study of 1,096 children with hemangiomas, 25 of whom met criteria for PHACE. These 25 patients represented 20% of infants with segmental facial hemangiomas. Compared to previous reports, our PHACE patients had a higher incidence of cerebrovascular and cardiovascular anomalies. Two developed acute arterial ischemic stroke during infancy, while two with cardiovascular anomalies showed documented evidence of normalization, suggesting that both progressive and regressive vascular phenomena may occur in this syndrome. Correlation to the anatomic location of the hemangioma appears to be helpful in determining which structural abnormalities might be present. A comparison of demographic and perinatal data between our PHACE cases and the hemangioma cohort overall showed no major differences, except a trend for PHACE infants to be of slighter higher gestational age and born to slightly older mothers. Eighty‐eight percent were female, a finding which has been noted in multiple other reports. Further research is needed to determine possible etiologies, optimal evaluation, and outcomes. © 2006 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
THE EPHRINS AND EPH RECEPTORS IN NEURAL DEVELOPMENT
Flanagan, J. G., & Vanderhaeghen, P. (1998) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.21.1.309 · Cited by 1,080
Haggstrom, A. N., Drolet, B. A., Baselga, E., Chamlin, S. L., Garzon, M. C., Horii, K. A., Lucky, A. W., Mancini, A. J., Metry, D. W., Newell, B., et al. (2006) · Pediatrics · doi:10.1542/peds.2006-0413 · Cited by 619
Self-citationSevere hypothyroidism caused by type 3 iodothyronine deiodinase in infantile hemangiomas
Huang, S. A., Tu, H. M., Harney, J. W., Venihaki, M., Butte, A. J., Kozakewich, H. P. W., Fishman, S. J., & Larsen, P. R. (2000) · New England Journal of Medicine · doi:10.1056/nejm200007203430305 · Cited by 540
Eph receptors and ephrins: effectors of morphogenesis
Holder, N., & Klein, R. (1999) · Development · doi:10.1242/dev.126.10.2033 · Cited by 442
Chiller, K. G., Passaro, D., & Frieden, I. J. (2002) · Archives of Dermatology · doi:10.1001/archderm.138.12.1567 · Cited by 422
Self-citationRamfrez-Solis, R., Zheng, H., Whiting, J., Krumlauf, R., & Bradley, A. (1993) · Cell · doi:10.1016/0092-8674(93)90229-j · Cited by 344
Thomas, P. Q. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.1.39 · Cited by 319
Haggstrom, A. N., Lammer, E. J., Schneider, R. A., Marcucio, R., & Frieden, I. J. (2006) · PEDIATRICS · doi:10.1542/peds.2005-1092 · Cited by 314
Self-citationStuder, M., Gavalas, A., Marshall, H., Ariza-McNaughton, L., Rijli, F. M., Chambon, P., & Krumlauf, R. (1998) · Development · doi:10.1242/dev.125.6.1025 · Cited by 311
The Nonrandom Distribution of Facial Hemangiomas
Waner, M., North, P. E., Scherer, K. A., Frieden, I. J., Waner, A., & Mihm, M. C. (2003) · Archives of Dermatology · doi:10.1001/archderm.139.7.869 · Cited by 284
Self-citationInduction of the Angiogenic Phenotype by Hox D3
Boudreau, N., Andrews, C., Srebrow, A., Ravanpay, A., & Cheresh, D. A. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.139.1.257 · Cited by 208
Homeobox B3 Promotes Capillary Morphogenesis and Angiogenesis
Myers, C. A., Charboneau, A. L., & Boudreau, N. J. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.148.2.343 · Cited by 152
Chen, J., & Ruley, H. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.38.24670 · Cited by 100
PHACES syndrome: a review of eight previously unreported cases with late arterial occlusions
Bhattacharya, J. J., Luo, C. B., �lvarez, H., Rodesch, G., Pongpech, S., & Lasjaunias, P. L. (2004) · Neuroradiology · doi:10.1007/s00234-002-0902-z · Cited by 97
The thyroid transcription factor‐1 gene is a candidate target for regulation by Hox proteins.
Guazzi, S., Lonigro, R. I., Pintonello, L., Boncinelli, E., Lauro, R. D., & Mavilio, F. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06636.x · Cited by 73
Nowak‐Göttl, U., Günther, G., Kurnik, K., Sträter, R., & Kirkham, F. J. (2003) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2003-42590 · Cited by 61
Risk factors for arterial ischemic stroke in childhood.
Kirkham, F. J., & Hogan, A. M. (2004) · PubMed · doi:10.1017/s1092852900009494 · Cited by 48
Hypopituitarism in PHACES Association
Goddard, D. S., Liang, M. G., Chamlin, S. L., Svoren, B. M., Spack, N. P., & Mulliken, J. B. (2006) · Pediatric Dermatology · doi:10.1111/j.1525-1470.2006.00287.x · Cited by 33
Self-citationFacial hemangioma and cerebral corticovascular dysplasia
Aeby, A., Guerrini, R., David, P., Rodesch, G., Raybaud, C., & Bogaert, P. V. (2003) · Neurology · doi:10.1212/01.wnl.0000052688.20517.7d · Cited by 24
Cited by
Consensus Statement on Diagnostic Criteria for PHACE Syndrome
Metry, D., Heyer, G., Hess, C., Garzon, M., Haggstrom, A., Frommelt, P., Adams, D., Siegel, D., Hall, K., Powell, J., et al. (2009) · Pediatrics · doi:10.1542/peds.2009-0082 · Cited by 401
Self-citation
Metadata
- Authors
- Metry, D. W., Haggstrom, A. N., Drolet, B. A., Baselga, E., Chamlin, S., Garzon, M., Horii, K., Lucky, A., Mancini, A. J., Newell, B., Nopper, A., Heyer, G., & Frieden, I. J.
- Venue
- American Journal of Medical Genetics Part A
- Publisher
- Wiley
- Published
- 2006-04-14
- Volume
- 140A
- Issue
- 9
- Pages
- 975-986
- ISSN
- 1552-4825 (ISSN-L)
- 1552-4833
- OpenAlex
- W2137390871
- Cited by
- 309
- References
- 19
- FWCI
- 16.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.